Find therapies in clinical trials near you – page 141

Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

Study on Denosumab for Healing Bone Fractures in Diabetic Patients with Charcot Foot

Study on Denosumab for Healing Bone Fractures in Diabetic Patients with Charcot Foot

Study on Anifrolumab for Patients with Primary Sjogren's Syndrome

Study on Anifrolumab for Patients with Primary Sjogren's Syndrome

Study on Eteplirsen for Patients with Duchenne Muscular Dystrophy with Deletion Mutations Amenable to Exon 51 Skipping

Study on Eteplirsen for Patients with Duchenne Muscular Dystrophy with Deletion Mutations Amenable to Exon 51 Skipping

Study on the Safety and Effectiveness of AZD7798 for Adults with Ileal Crohn's Disease and an Ileostomy

Study on the Safety and Effectiveness of AZD7798 for Adults with Ileal Crohn's Disease and an Ileostomy

Study on Atezolizumab and Tiragolumab for Patients with Head and Neck Cancer, Metastatic Melanoma, and Other Advanced Solid Tumors

Study on Atezolizumab and Tiragolumab for Patients with Head and Neck Cancer, Metastatic Melanoma, and Other Advanced Solid Tumors

Study on the Safety of Donidalorsen for Patients with Hereditary Angioedema

Study on the Safety of Donidalorsen for Patients with Hereditary Angioedema

Study of tacrolimus, everolimus and mycophenolate mofetil combination in elderly patients after kidney transplant

Study of tacrolimus, everolimus and mycophenolate mofetil combination in elderly patients after kidney transplant

Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Untreated Advanced Triple-Negative Breast Cancer

Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Untreated Advanced Triple-Negative Breast Cancer

Study of Setmelanotide for Patients with Obesity Due to Specific Genetic Variants

Study of Setmelanotide for Patients with Obesity Due to Specific Genetic Variants

Study Comparing Sacituzumab Govitecan to Physician's Choice Treatment for Patients with Advanced Triple-Negative Breast Cancer

Study Comparing Sacituzumab Govitecan to Physician's Choice Treatment for Patients with Advanced Triple-Negative Breast Cancer

Study of lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

Study of lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa